Andreessen Horowitz

4 items

Wall Street Journal 2026-04-20-2

Marc Benioff Says the Software Bears Are All Wrong About Salesforce

Salesforce just disclosed 2.4 billion Agentic Work Units growing 57% quarter over quarter, with no dollar anchor attached and revenue still crawling at 10%. CEOs don't write op-eds when they're winning; 15.3% Agentforce penetration after 18 months reads as a chasm signal, not acceleration, and Kimbarovsky sold shares from the exact article Benioff sanctioned. The scaffolding moat is real for regulated enterprise, but the AWU-without-price pattern is stage one of a per-seat-to-per-action transition Salesforce hasn't finished pricing yet.

Bloomberg 2026-04-07-3

What Is ARR? Behind the Least-Trusted Metric of the AI Era

ARR has no SEC definition, no audit standard, and no standardized calculation: the metric Silicon Valley uses to price AI startups is whatever the founder needs it to mean. The real problem is structural, not behavioral: consumption-based, credits-based, and outcome-based AI pricing models don't map to the subscription framework ARR was built for. Every 25-30x multiple applied to unverified AI ARR is a bet on retention data that doesn't exist yet.

Wired 2026-03-16-2

Can AI Kill the Venture Capitalist?

The real VC disruption isn't AI replacing analysts: it's AI eliminating the customer. When a $300M-revenue company can reach unicorn status with 100 people and zero venture funding, the disruption is demand-side: startups don't need the capital. The "Moneyball for VC" thesis is flattering but structurally wrong; VC has a data poverty problem, not a data utilization problem.

Wall Street Journal 2026-03-08-3

Can AI Replace Humans for Market Research?

$100M Series A announcement dressed as trend piece. CVS's "95% accuracy" claim is backtested against known answers — the real test is predicting unknown findings, which nobody's shown. Digital twins for market research are a cost/speed optimization, not a new form of intelligence. The hard-to-reach population simulation (chronic disease patients from sparse data) is where overconfidence becomes actively dangerous.